Patients: 205 patients > 60 years of age (mean age 80 y, 54% women) who were enrolled in the clinic's Employee and Community Health program and had an Elder Risk Assessment Index score > 15 (based on age, sex, previous hospitalizations, and comorbid conditions [stroke, dementia, heart disease, diabetes mellitus, and chronic obstructive pulmonary disease]). Exclusion criteria were residence in a nursing home, dementia, Kokmen mental status score ≤ 29, and inability to use the telemonitoring device.
Intervention: Home telemonitoring using the Intel Health Guide (Intel-GE) device (n = 102) or usual care (n = 103). Telemonitoring comprised daily patient entry of symptoms and biometrics using peripheral scales, blood pressure cuff, glucometer, pulse oximeter, and peak flow meter. Data were reviewed daily by registered nurses who triaged patients using decision support from the medical record, consulted with primary physicians, and communicated with patients by telephone or videoconference as needed.
Outcomes: Primary outcome was a composite of hospitalizations and ED visits. Secondary outcomes included hospitalizations, ED visits, and mortality. With 100 patients per group, the study had 80% power to detect a 36% relative reduction (from 38% to 24%) in the composite endpoint at 1 year (α = 0.05).
Patient follow-up: 81% (intention-to-treat analysis).

Main results
Telemonitoring did not reduce hospitalizations or ED visits, combined or alone, but increased mortality (Table) .
Conclusions
In high-risk elderly patients, telemonitoring did not reduce hospitalizations or emergency department visits compared with usual care but increased mortality. 
Commentary
The results of the study by Takahashi and colleagues will probably curb the enthusiasm of many health care systems considering investing in home-monitoring systems to reduce costly ED visits and acute hospitalizations. Why have innovative telemonitoring interventions not proven to be of more value for "bending the cost curve?" This may be an indictment of misalignments in health care systems rather than inadequacy of the technology. Telemonitoring of health status in community-living, older adults at high risk for hospitalization is an example of a sustaining innovationthat is, it replaces costly ambulatory visits with potentially more cost-effective, remote visual communication with patients and uses ancillary technology to assess vital signs and some laboratory studies. Where telemonitoring seems to fail is that the responsibility for follow-up is left to busy primary care offices that do not have provisions or incentives to act other than the customary referral to EDs or hospitals. However, better alignment of incentives for all participants is being proposed in medical home models and accountable care organizations. Health systems that have aligned incentives among their entire health care workforce may embrace telemonitoring as a key strategy for providing care and reducing costs. At that point, any technology that facilitates more human communication with patients with chronic illness and, most important, has resources to ensure appropriate follow-up, will be considered a disruptive innovation and will probably enhance health delivery for both patients and providers. Meanwhile, the study of Takahashi and colleagues does provide evidence that technology cannot substitute for sound health care delivery design and function-and may even accentuate delivery deficiencies. Future proposals for telemonitoring will need to be developed, realized, and tested before they can be recommended and should not ignore the lessons learned along the way. 
